Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.
Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
BMC Biol. 2022 May 13;20(1):112. doi: 10.1186/s12915-022-01309-z.
MAPK/ERK signaling is a well-known mediator of extracellular stimuli controlling intracellular responses to growth factors and mechanical cues. The critical requirement of MAPK/ERK signaling for embryonic stem cell maintenance is demonstrated, but specific functions in progenitor regulation during embryonic development, and in particular kidney development remain largely unexplored. We previously demonstrated MAPK/ERK signaling as a key regulator of kidney growth through branching morphogenesis and normal nephrogenesis where it also regulates progenitor expansion. Here, we performed RNA sequencing-based whole-genome expression analysis to identify transcriptional MAPK/ERK targets in two distinct renal populations: the ureteric bud epithelium and the nephron progenitors.
Our analysis revealed a large number (5053) of differentially expressed genes (DEGs) in nephron progenitors and significantly less (1004) in ureteric bud epithelium, reflecting likely heterogenicity of cell types. The data analysis identified high tissue-specificity, as only a fraction (362) of MAPK/ERK targets are shared between the two tissues. Tissue-specific MAPK/ERK targets participate in the regulation of mitochondrial energy metabolism in nephron progenitors, which fail to maintain normal mitochondria numbers in the MAPK/ERK-deficient tissue. In the ureteric bud epithelium, a dramatic decline in progenitor-specific gene expression was detected with a simultaneous increase in differentiation-associated genes, which was not observed in nephron progenitors. Our experiments in the genetic model of MAPK/ERK deficiency provide evidence that MAPK/ERK signaling in the ureteric bud maintains epithelial cells in an undifferentiated state. Interestingly, the transcriptional targets shared between the two tissues studied are over-represented by histone genes, suggesting that MAPK/ERK signaling regulates cell cycle progression and stem cell maintenance through chromosome condensation and nucleosome assembly.
Using tissue-specific MAPK/ERK inactivation and RNA sequencing in combination with experimentation in embryonic kidneys, we demonstrate here that MAPK/ERK signaling maintains ureteric bud tip cells, suggesting a regulatory role in collecting duct progenitors. We additionally deliver new mechanistic information on how MAPK/ERK signaling regulates progenitor maintenance through its effects on chromatin accessibility and energy metabolism.
MAPK/ERK 信号是一种众所周知的细胞外刺激调节剂,可控制生长因子和机械线索引起的细胞内反应。MAPK/ERK 信号对胚胎干细胞维持的关键要求已得到证实,但在胚胎发育过程中祖细胞调节以及特别是肾脏发育中的具体功能在很大程度上仍未得到探索。我们之前的研究表明,MAPK/ERK 信号是通过分支形态发生和正常肾发生来调节肾脏生长的关键调节剂,在这些过程中,它还调节祖细胞的扩增。在这里,我们通过基于 RNA 测序的全基因组表达分析,鉴定了两个不同的肾脏群体中的转录 MAPK/ERK 靶标:输尿管芽上皮和肾祖细胞。
我们的分析显示,在肾祖细胞中有大量(5053)差异表达基因(DEGs),而在输尿管芽上皮中则显著较少(1004),反映了细胞类型的异质性。数据分析表明组织特异性很高,因为两个组织之间只有一小部分(362)MAPK/ERK 靶标是共享的。组织特异性 MAPK/ERK 靶标参与肾祖细胞中线粒体能量代谢的调节,而在 MAPK/ERK 缺陷组织中,这些靶标无法维持正常的线粒体数量。在输尿管芽上皮中,检测到祖细胞特异性基因表达的急剧下降,同时分化相关基因的增加,而在肾祖细胞中则没有观察到这种情况。我们在 MAPK/ERK 缺陷遗传模型中的实验提供了证据,表明 MAPK/ERK 信号在输尿管芽中维持上皮细胞处于未分化状态。有趣的是,在研究的两个组织中共享的转录靶标被组蛋白基因所代表,这表明 MAPK/ERK 信号通过染色体浓缩和核小体组装来调节细胞周期进程和干细胞维持。
使用组织特异性 MAPK/ERK 失活和 RNA 测序,并结合胚胎肾脏中的实验,我们在这里证明 MAPK/ERK 信号维持输尿管芽尖端细胞,提示其在集合管祖细胞中的调节作用。我们还提供了有关 MAPK/ERK 信号如何通过影响染色质可及性和能量代谢来调节祖细胞维持的新的机制信息。